Get the Daily Brief
Latest Biotech News
FDA Clears Precigen’s Gene Therapy for Rare Respiratory Disease
The U.S. Food and Drug Administration granted full and expedited approval to Precigen Inc.’s gene therapy Papzimeos for adults with recurrent respiratory papillomatosis (RRP), a rare chronic...
MIT AI Generates Antibiotics Against Drug-Resistant Bacteria
Researchers at MIT and collaborators have developed generative artificial intelligence methods to design novel antibiotic compounds effective against multidrug-resistant pathogens, including...
Eli Lilly’s $1.3B Deal with Superluminal Targets Obesity and Cardiometabolic Diseases
Eli Lilly has entered a significant collaboration with Superluminal Medicines in a deal potentially worth $1.3 billion, including upfront payments, equity investments, development and commercial...
CD40 Agonist Antibody Shows Tumor Eradication in Metastatic Cancer Trial
A first-in-human Phase I clinical trial demonstrated promising efficacy of an Fc-optimized CD40 agonistic antibody (2141.V11) delivered via intratumoral injection in 12 metastatic cancer patients....
Real-Time 3D Imaging Captures Human Embryo Implantation
For the first time, researchers from the Institute for Bioengineering of Catalonia and Dexeus University Hospital have recorded human embryo implantation in real time using 3D microscopy on...
Elysium Develops Longer-Lasting Opioid Overdose Antidote
Elysium Therapeutics is advancing its Synthetic Opioid Overdose Prevention and Reversal (SOOPR) program to address fentanyl rebound, a phenomenon where existing opioid antagonists lose effect...
New Research Elucidates Sex Differences in Acute Kidney Injury
A team of German researchers discovered that estrogen confers protection against acute kidney injury (AKI) by inhibiting ferroptosis—a form of programmed cell death—in renal tubule cells. This...
Bionano Reports Q2 Revenue Decline Amid Strategic Shift
Bionano Genomics reported a 13% revenue decrease in Q2 2025 to $6.7 million, reflecting business restructuring focused on optical genome mapping and Via software routine users. Product sales...
AI Advances Transform Drug Discovery and Structural Biology
Cutting-edge artificial intelligence models are revolutionizing biomedical research, as exemplified by the development of PepMLM, an AI that designs peptide binders without structural data,...
Eli Lilly's Global Pricing Strategy Raises Drug Prices in Europe
Eli Lilly announced plans to significantly increase the prices of its weight-loss drug Mounjaro in the UK and other European markets, in an effort to reduce costs in the United States. The price...
CD40 Agonist Antibody Shows Systemic Tumor Control in Early Trial
A novel Fc-optimized CD40 agonistic antibody demonstrated promising antitumor activity in a Phase I trial involving 12 metastatic cancer patients. Administered via intratumoral injection, the...
Precigen’s Gene Therapy Secures Fast FDA Approval for Rare Disease
Precigen Inc. received swift and full FDA approval for Papzimeos (zopapogene imadenovec), a gene therapy for adults with recurrent respiratory papillomatosis (RRP), a rare disease marked by benign...
AI-Driven Antibiotic Design Yields Novel Compounds Against Resistant Bacteria
Researchers at MIT utilized generative artificial intelligence to design structurally novel antibiotics targeting drug-resistant Neisseria gonorrhoeae and MRSA. Screening millions of AI-generated...
Human Embryo Implantation Captured in Real Time with 3D Imaging
For the first time, researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital recorded real-time, three-dimensional images and videos of a human embryo implanting...
Eli Lilly Raises Drug Prices in Europe to Lower US Costs Amid Political Pressure
Eli Lilly announced significant price hikes for its weight-loss drug Mounjaro in the United Kingdom, increasing the list price by approximately 170%. This move aligns with the Trump...
Elysium Therapeutics Develops Longer-Lasting Opioid Overdose Antidote
Elysium Therapeutics is advancing a novel rescue agent designed to address the problem of fentanyl rebound, or re-narcotization, after opioid overdose. Current opioid antagonists like naloxone...
Study Uncovers Estrogen’s Protective Role Against Acute Kidney Injury in Females
German researchers resolved a longstanding question regarding the sex disparity in susceptibility to acute kidney injury (AKI). Their study demonstrated that estrogen exerts a protective effect in...
Breakthrough in Lung Cancer Therapy Using Precision Nanobody Technology
Researchers at Korea Research Institute of Bioscience and Biotechnology developed a nanobody-based therapy enabling highly selective targeting of lung cancer cells. This technology offers...
Mount Sinai Continues as Official Medical Provider for US Open Tennis
Mount Sinai Health System marks its 13th consecutive year serving as the official hospital and medical services provider for the US Open Tennis Championships. The partnership reinforces Mount...
Bionano Genomics Reports Revenue Decline Despite Product Sales Growth
Bionano Genomics reported a 13% year-over-year decline in total revenues for Q2 2025, totaling $6.7 million driven primarily by a 67% drop in service revenues despite a 3% decrease in product...